Cardiology Calculators
156 calculators & risk scores
Browse 156 Cardiology clinical calculators and risk scores used in everyday UK practice. Every tool runs entirely in your browser — enter the values and get instant scoring, colour-coded interpretation bands and a link to the underlying guideline or publication. ClinCalc Pro is free, needs no sign-up, and is built for working clinicians.
These cardiology tools span Atrial Fibrillation, Bleeding Risk, ACS, ECG, Heart Failure, Cardiovascular Risk and more.
- CHA₂DS₂-VASc ScoreEstimates annual stroke risk in non-valvular atrial fibrillation to guide anticoagulation.
- HAS-BLED ScoreEstimates 1-year risk of major bleeding in anticoagulated patients with AF.
- TIMI Risk Score for STEMIPredicts 30-day mortality in ST-elevation myocardial infarction (STEMI).
- GRACE ACS Risk ScoreGRACE risk score (in-hospital death nomogram, Granger 2003): estimates in-hospital mortality across the spectrum of acute coronary syndromes from 8 admission variables.
- Corrected QT Interval (Bazett)Corrects QT interval for heart rate using Bazett's formula. Identifies prolonged QTc risk.
- NYHA Heart Failure ClassificationClassifies heart failure severity based on functional limitation from symptoms.
- Framingham Risk ScoreEstimates 10-year coronary heart disease risk in men aged 30–74 without CHD — Wilson 1998 categorical points (total-cholesterol version for men).
- Cardiac Output (Fick Method)Calculates cardiac output using the Fick principle: VO₂ divided by arteriovenous O₂ difference.
- Mean Arterial Pressure (MAP)Calculates mean arterial pressure from systolic and diastolic blood pressure. MAP reflects perfusion pressure to vital organs.
- Shock IndexRatio of heart rate to systolic blood pressure. Identifies haemodynamically unstable patients and predicts mortality in various emergency conditions including trauma, sepsis, and obstetric emergencies.
- Revised Cardiac Risk Index (RCRI)Lee's Revised Cardiac Risk Index estimates the risk of major cardiac events (MI, cardiac arrest, complete heart block, pulmonary oedema) in non-cardiac surgery
- CHADS₂ Score for AF Stroke RiskOriginal CHADS₂ score for estimating stroke risk in non-valvular atrial fibrillation. Largely superseded by CHA₂DS₂-VASc but still widely referenced.
- Duke Criteria for Infective EndocarditisModified Duke Criteria stratify patients into definite, possible, or rejected infective endocarditis (IE) based on major and minor clinical and microbiological criteria
- Brugada Criteria for Ventricular Tachycardia4-step algorithm to differentiate ventricular tachycardia (VT) from supraventricular tachycardia (SVT) with aberrancy on a 12-lead ECG. Sensitivity ~99%, specificity ~97% for VT.
- Sgarbossa Criteria for MI in LBBBIdentifies acute MI in the presence of left bundle branch block from 3 weighted ECG criteria (Sgarbossa 1996; score ≥ 3 positive). The Smith-modified rule replaces the ≥ 5 mm discordant ST elevation criterion with an ST/S ratio ≤ −0.25 and is unweighted.
- CRUSADE Bleeding Risk ScoreEstimates the risk of in-hospital major bleeding in patients with NSTEMI/ACS. Considers haematocrit, creatinine clearance, heart rate, sex, signs of heart failure, prior vascular disease, diabetes, and SBP.
- DASH Prediction Score for Recurrent VTEPredicts the annual risk of recurrent VTE after discontinuing anticoagulation following a first unprovoked VTE event, to guide duration of therapy
- Duke Activity Status Index (DASI)Estimates functional capacity (metabolic equivalents, METs) from self-reported ability to perform 12 common activities of daily living. Used for pre-operative cardiac risk assessment.
- Rate-Pressure Product (RPP)Estimates myocardial oxygen demand as the product of heart rate and systolic blood pressure. Used to assess cardiovascular workload during exercise testing or perioperative monitoring.
- Killip Classification for Acute MIClassifies severity of acute myocardial infarction based on clinical features of heart failure. Predicts in-hospital mortality.
- EuroSCORE IIPredicts in-hospital mortality after adult cardiac surgery. Replaces additive and logistic EuroSCORE.
- HEMORR₂HAGES Bleeding Risk ScoreEstimates annual major bleeding risk in AF patients on anticoagulation. 11-component mnemonic score.
- HEART Score for Major Adverse Cardiac Events5-component score predicting 6-week MACE (death, MI, revascularisation) in ED chest pain. Score ≥ 4 warrants admission and further workup.
- TIMI Risk Score for UA/NSTEMI7-point score predicting 14-day risk of all-cause mortality, new or recurrent MI, or severe recurrent ischaemia requiring revascularisation in UA/NSTEMI.
- EDACS — Emergency Department Assessment of Chest PainScore for low-risk chest pain in the ED, intended for use with 2h serial troponin to identify patients safe for early discharge. Validated with high-sensitivity troponin.
- ATRIA Bleeding Risk ScorePredicts major bleeding risk in patients with atrial fibrillation on warfarin anticoagulation. Complements HAS-BLED.
- MAGGIC Risk Score for Heart FailureMeta-Analysis Global Group in Chronic Heart Failure (MAGGIC) score predicts 1-year and 3-year all-cause mortality in chronic heart failure.
- ATRIA Stroke Risk Score for Atrial FibrillationPredicts stroke/thromboembolism risk in AF patients. Continuous score 0–15. Developed from the ATRIA study (13 000+ AF patients).
- Gupta Perioperative Risk for MI or Cardiac Arrest (MICA)Predicts the risk of perioperative myocardial infarction or cardiac arrest (NSQIP-derived logistic model, Gupta 2011) from age, functional status, ASA class, creatinine and type of surgery.
- ADHERE Algorithm for Acute Decompensated Heart FailureStratifies mortality risk in hospitalised acute decompensated heart failure using 3 readily available parameters. Simple decision tree.
- Modified Shock Index (MSI)MSI = Heart Rate / Mean Arterial Pressure. More sensitive than standard shock index for detecting haemodynamic instability in trauma, sepsis, and haemorrhage.
- Fridericia Corrected QT Interval (QTcF)Corrects QT interval for heart rate using cube root formula. Preferred over Bazett at extremes of heart rate (tachycardia/bradycardia).
- Caprini Score for VTE Risk (2005)Caprini 2005 risk assessment model for venous thromboembolism (VTE) in surgical patients; guides thromboprophylaxis. Women-only items: hormones, pregnancy/postpartum, obstetric history.
- IMPROVE VTE Risk Score for Medical PatientsPredicts VTE risk in hospitalised medical (non-surgical) patients. Guides pharmacological thromboprophylaxis decisions.
- ACC/AHA Pooled Cohort Equations — ASCVD RiskEstimates 10-year risk of first atherosclerotic cardiovascular event (MI or fatal CVD) in patients without prior ASCVD. Guides statin therapy decisions.
- TIMI Risk Index for STEMISimple bedside risk index predicting 30-day mortality in STEMI. Calculated as: heart rate × (age/10)² / systolic BP.
- Modified Sgarbossa's Criteria (Smith Modification) for MI in LBBBModified version of Sgarbossa criteria using proportional (ratio-based) ST deviation rather than absolute 5 mm threshold for identifying STEMI in LBBB/paced rhythm.
- Brugada Phenocopy ScoreDistinguishes true Brugada syndrome from Brugada phenocopy (BrP) — transient Brugada ECG pattern due to reversible conditions. High score = true Brugada syndrome.
- PREVENT Cardiovascular Risk Calculator (AHA/ACC 2023)AHA/ACC 2023 PREVENT equations predict 10- and 30-year risk of total cardiovascular disease (CVD) events including heart failure. Replaces pooled cohort equations. Validated across diverse populations.
- HE-MACS (History and ECG-only Manchester Acute Coronary Syndromes)Probability of acute coronary syndrome from history, examination and ECG only — no troponin — to identify very-low-risk chest pain at triage. Derived and validated in UK emergency departments.
- HFSA Risk Score for Heart FailureInformation page: the Heart Failure Society of America has not published a risk score for acute heart failure. Validated alternatives are named on the page.
- ABC-Bleeding Score for Anticoagulated Atrial FibrillationBiomarker-based bleeding risk score for patients with AF on oral anticoagulation. Outperforms HAS-BLED in some cohorts. Uses troponin, GDF-15, and haemoglobin alongside clinical variables.
- San Francisco Syncope RuleIdentifies high-risk syncope patients requiring urgent evaluation. Mnemonic: CHESS.
- OESIL Score for SyncopePredicts 12-month all-cause mortality in patients with syncope.
- EGSYS Score for SyncopeDifferentiates cardiac from non-cardiac syncope. Score ≥3 suggests cardiac aetiology.
- ROSE Rule for SyncopeRisk Stratification of Syncope in the Emergency Department. Any criterion = high risk.
- Boston Syncope CriteriaIdentifies high-risk syncope features requiring hospital admission.
- ACC/AHA Heart Failure StagingClassifies heart failure progression into stages A–D to guide therapy and prognosis.
- Framingham Heart Failure Diagnostic CriteriaDiagnoses clinical heart failure. Requires 2 major OR 1 major + 2 minor criteria.
- H2FPEF Score for HFpEFEstimates probability of Heart Failure with Preserved Ejection Fraction (HFpEF) in patients with unexplained dyspnoea.
- Ottawa Heart Failure Risk ScaleIdentifies ED patients with acute heart failure at high risk for serious adverse events within 14 days.
- GWTG-HF Risk Score for In-Hospital MortalityPredicts in-hospital mortality for acute heart failure using admission variables.
- HEAR Score for Acute Chest PainHEART score without its troponin item. A HEAR score < 2 identifies chest pain at very low risk of 30-day AMI or death, in whom troponin testing might be avoided (Moumneh 2021).
- ACTION ICU Score for Intensive Care in NSTEMIPredicts which initially haemodynamically stable NSTEMI patients will develop a complication needing ICU care (cardiac arrest, shock, high-grade AV block, respiratory failure, stroke or death) in hospital. Derived in the ACTION Registry–GWTG; less tested in younger patients.
- Marburg Heart ScoreEstimates probability of cardiac chest pain in primary care settings.
- INTERCHEST Clinical Prediction RuleRules out coronary artery disease in primary-care chest pain. A score < 2 means coronary artery disease is unlikely (pooled data from five countries).
- ORBIT Bleeding Risk Score for AFPredicts major bleeding risk in atrial fibrillation patients on anticoagulation.
- HERDOO2 Rule for Discontinuing Anticoagulation in Unprovoked VTEIdentifies low-risk women with unprovoked VTE who can safely discontinue anticoagulation. Not validated in men.
- DAPT ScoreDetermines whether to continue dual antiplatelet therapy (DAPT) beyond 12 months after PCI with drug-eluting stent.
- RIETE Score for Bleeding Risk in VTEPredicts risk of major bleeding during first 3 months of anticoagulation for VTE.
- IE 6-Month Mortality Risk Score (ICE)Predicts 6-month mortality in definite infective endocarditis from host factors, IE characteristics, complications and surgical treatment (International Collaboration on Endocarditis).
- CHA₂DS₂-VA Score for AF (ESC 2024)2024 ESC atrial fibrillation guideline stroke-risk score: CHA₂DS₂-VASc without the sex category. Oral anticoagulation is recommended at a score of 2 or more and should be considered at a score of 1.
- CHADS-65 for Atrial FibrillationCanadian Cardiovascular Society (CCS) simplified guideline for anticoagulation in AF. Age ≥65 or CHADS2 ≥1 → anticoagulate.
- Tisdale Risk Score for QT ProlongationPredicts risk of drug-induced QT prolongation in hospitalised patients.
- ACEF II Risk Score for Cardiac SurgeryPredicts 30-day mortality after elective or emergency cardiac surgery using simple preoperative variables.
- Thakar Score for Acute Renal Failure after Cardiac SurgeryPredicts risk of acute renal failure requiring dialysis after cardiac surgery.
- Cardiac Anaesthesia Risk Evaluation (CARE) ScoreSimple anaesthesiologist-assigned risk classification for cardiac surgery based on urgency and comorbidities.
- Mehran Score for Post-PCI Contrast NephropathyPredicts risk of contrast-induced nephropathy (CIN) following percutaneous coronary intervention (PCI).
- Aortic Dissection Detection Risk Score (ADD-RS)Risk-stratifies patients with suspected acute aortic dissection (0–3: one point per category of high-risk conditions, pain features and examination findings). A score of 0 alone does not rule out dissection; ADD-RS ≤ 1 with D-dimer < 500 ng/mL had a 0.3 % failure rate (ADvISED).
- RoPE Score for Patent Foramen OvaleEstimates probability that a patent foramen ovale (PFO) is responsible for a cryptogenic stroke. Higher score = PFO more likely to be causal.
- Canadian Cardiovascular Society (CCS) Angina GradingClassifies severity of angina pectoris into functional classes to guide investigation and treatment.
- Duke Treadmill ScorePredicts cardiovascular mortality risk from exercise stress testing. Score = Exercise time (min) − (5 × ST deviation mm) − (4 × Angina index).
- Cardiac Power Output (CPO)Measures cardiac mechanical power — strongest haemodynamic predictor of mortality in cardiogenic shock. CPO = (MAP × CO) / 451.
- Reynolds Risk Score for WomenPredicts 10-year cardiovascular event risk in women ≥ 45 years without prior CVD, adding hsCRP and family history to traditional risk factors.
- GO-FAR Score for Post-CPR SurvivalPredicts neurologically intact survival to hospital discharge after in-hospital CPR. Assists goals-of-care discussions.
- HCM Risk-SCD for Hypertrophic CardiomyopathyEstimates 5-year risk of sudden cardiac death (SCD) in hypertrophic cardiomyopathy to guide ICD implantation (ESC 2014 model).
- ARC-HBR Criteria for High Bleeding Risk in PCIAcademic Research Consortium for High Bleeding Risk (ARC-HBR) criteria. HBR = 1 major OR ≥ 2 minor criteria. Guides DAPT duration post-PCI.
- SCORE2 — 10-Year CVD Risk (Age 40–69)European Heart Score 2 — estimates 10-year risk of fatal and non-fatal cardiovascular events for adults aged 40–69 without known CVD or diabetes.
- SCORE2-OP — 5/10-Year CVD Risk (Age ≥ 70)SCORE2 for Older Persons — estimates 5-year and 10-year CVD risk in adults aged ≥ 70 years without established CVD.
- Subtle Anterior STEMI Calculator (4-Variable)Differentiates subtle anterior STEMI (LAD occlusion) from normal-variant ST elevation (early repolarisation) using QTc, QRS amplitude in V2, R-wave amplitude in V4 and ST elevation 60 ms after the J-point in V3 (Driver 2017 4-variable formula). A value ≥ 18.2 favours LAD occlusion.
- REVEAL 2.0 Risk Score for Pulmonary Arterial HypertensionREVEAL 2.0 (Benza 2019) predicts 1-year mortality in WHO group 1 pulmonary arterial hypertension from 13 variables (score 0–23). A test not done scores 0.
- PRECISE-DAPT Score for Bleeding on DAPTPredicts out-of-hospital bleeding risk during dual antiplatelet therapy (DAPT) to guide DAPT duration decisions post-PCI.
- 2023 Duke-ISCVID Criteria for Infective EndocarditisUpdated 2023 Duke criteria incorporating CT, PET-CT, and MRI findings for IE diagnosis. Classification: Definite, Possible, or Rejected.
- CART Score for Cardiac Arrest Risk TriageCardiac Arrest Risk Triage (CART) score (Churpek 2012): ward respiratory rate, heart rate, diastolic BP and age predict ward cardiac arrest (AUC 0.84); it flagged arrests a median of 48 hours before the event.
- EUROMACS-RHF Score for Right Heart Failure after LVADPredicts severe right heart failure (RHF) requiring short-term mechanical circulatory support after LVAD implantation.
- ADAPT Protocol for Cardiac Event Risk2-hour accelerated diagnostic protocol (ADAPT) for chest pain: TIMI score, ECG, and troponin I at 0 and 2 hours (contemporary sensitive assays). Identifies low-risk patients suitable for early discharge (1 of 392 low-risk patients, 0.25 %, had a 30-day MACE).
- GARFIELD-AF Risk Score for Atrial FibrillationRisk model from the Global Anticoagulant Registry in the FIELD-AF study. Predicts 1-year risk of stroke/SE, major bleeding, and all-cause mortality in newly diagnosed non-valvular AF. Adds smoking and renal function to traditional CHA2DS2-VASc variables.
- SCORE2-Diabetes 10-Year CVD Risk in Type 2 DiabetesSCORE2-Diabetes (ESC 2023) estimates 10-year cardiovascular risk in people with type 2 diabetes without established atherosclerotic cardiovascular disease.
- T-MACS Troponin-Only Manchester ACS Decision AidSingle time-point decision aid combining arrival high-sensitivity troponin T (Roche) with 6 clinical features to estimate the probability of acute coronary syndrome (Body 2017). Very low risk (< 2 %) supports rule-out at presentation; ≥ 95 % rules in.
- Emergency Heart Failure Mortality Risk Grade (EHMRG)Predicts 7-day mortality in emergency department patients with acute heart failure from triage vital signs, creatinine, potassium, troponin, active cancer and home metolazone (Ontario derivation and validation, Lee 2012).
- CAHP Cardiac Arrest Hospital Prognosis ScoreClinical score predicting neurological outcome (CPC 1 or 2 at 30 days) in patients resuscitated from out-of-hospital cardiac arrest. Based on 7 variables at ED arrival. Validated in French multicentre cohorts. Low score indicates favourable neurological outcome.
- VIRSTA Score for Infective Endocarditis Risk in BacteraemiaVIRSTA (Tubiana 2016): risk of infective endocarditis in adults with Staphylococcus aureus bacteraemia, assessed within 48 hours, to prioritise echocardiography. Score ≥ 3: echocardiography.
- DOAC Score for Selecting Direct Oral Anticoagulant in Non-Valvular AFInformation page: choosing and dosing a direct oral anticoagulant in non-valvular atrial fibrillation.
- Seattle Heart Failure Model (SHFM)Multivariable model for predicting 1-year and mean survival in patients with heart failure. Validated in over 9,000 patients across multiple trials. Estimates absolute and relative benefit of HF interventions.
- SEX-SHOCK Risk Score for Cardiogenic Shock Development in ACSSEX-SHOCK (Wang 2024) predicts in-hospital cardiogenic shock after acute coronary syndrome treated with PCI, using separate models for women and men.
- SAVE Score for Survival After Veno-Arterial ECMO (VA-ECMO)SAVE score (Schmidt 2015): pre-ECMO prediction of in-hospital survival for adults receiving veno-arterial ECMO for refractory cardiogenic shock.
- PFO-Associated Stroke Causal Likelihood (PASCAL) ClassificationClassifies how likely a PFO caused an otherwise cryptogenic ischaemic stroke (adults 18–60) by combining the RoPE score with high-risk PFO features, to guide PFO closure decisions.
- RESCUE-IHCA Score for ECPR in In-Hospital Cardiac ArrestRESCUE-IHCA (Tonna 2022) predicts in-hospital death in adults receiving extracorporeal CPR (ECPR) for in-hospital cardiac arrest.
- Gillmore Staging System for Transthyretin Amyloid Cardiomyopathy (ATTR-CM)Three-stage clinical staging system for transthyretin amyloid cardiomyopathy (ATTR-CM) based on NT-proBNP and eGFR. Predicts median survival and guides treatment eligibility (tafamidis, TTR gene silencers).
- Bazett Corrected QT Interval (QTc) CalculatorCalculates heart rate-corrected QT interval (QTc) using the Bazett formula (most widely used clinically). Prolonged QTc is associated with risk of Torsades de Pointes and sudden cardiac death.
- HAT (Haemorrhage After Thrombolysis) Score for Post-tPA Haemorrhage RiskPredicts risk of symptomatic intracerebral haemorrhage (sICH) after IV tPA (alteplase) thrombolysis in acute ischaemic stroke. Calculated at admission, before tPA administration.
- HOPE Score (Hypothermia Outcome Prediction after ECLS)Probability of survival to hospital discharge after extracorporeal life support (ECLS) rewarming for cardiac arrest from accidental hypothermia. Not for normothermic cardiac arrest.
- ORBI Risk Score after Primary PCI in STEMIInformation page: the ORBI (Observatoire Régional Breton sur l'Infarctus) score predicts in-hospital cardiogenic shock in STEMI treated by primary PCI; there is no published ORBI bleeding score.
- AMI READMITS Score for 30-Day Readmission After Acute MIPredicts 30-day all-cause readmission after acute myocardial infarction from seven variables available on the first day of admission (Nguyen 2018; derived in six Texas hospitals, not externally validated).
- Steinhart Model for Acute Heart Failure in Undifferentiated DyspnoeaThe Steinhart model (2009) combines the clinician's pre-test probability of acute heart failure with age and NT-proBNP in breathless emergency department patients.
- PCP-HF Risk Score (Pooled Cohort Equations to Prevent Heart Failure)10-year risk prediction model for incident heart failure in patients without current HF. Uses clinical and laboratory variables to identify patients who may benefit from primary HF prevention strategies.
- AUB-HAS2 Cardiovascular Risk IndexAmerican University of Beirut (AUB-HAS2) Cardiovascular Risk Index: predicts death, myocardial infarction or stroke within 30 days of non-cardiac surgery from 6 elements. Derived in adults ≥ 40 years; validated in 1.17 million NSQIP patients.
- Grogan Staging System for Transthyretin Amyloid Cardiomyopathy (ATTR-CM)Mayo Clinic three-stage staging for wild-type transthyretin cardiac amyloidosis using NT-proBNP and troponin T (derived in 360 patients). Complements the Gillmore system, which uses eGFR.
- Composite Pulmonary Embolism Shock (CPES) ScoreIdentifies high-risk pulmonary embolism patients at risk for haemodynamic deterioration and cardiogenic shock requiring reperfusion (thrombolysis or embolectomy). Complements PESI and sPESI in intermediate-risk PE.
- Cardiovascular Risk in Orthotopic Liver Transplantation (CAR-OLT) ScorePredicts the 1-year risk of a cardiovascular complication (cardiovascular death, or hospitalisation for MI, revascularisation, heart failure, AF, cardiac arrest, PE, TIA or stroke) after liver transplantation, from pre-transplant factors. Comorbidities are coded as history before transplant.
- ORBIT Bleeding Risk Score for Anticoagulation in AF PatientsORBIT (Outcomes Registry for Better Informed Treatment of Atrial Fibrillation) bleeding risk score for predicting major bleeding during anticoagulation for atrial fibrillation. Validated in over 7,400 AF patients.
- Cardiac Output by Thermodilution (Fick Principle) CalculatorCalculates cardiac output, cardiac index, and stroke volume from invasive haemodynamic measurements. Uses the Fick principle (O2 consumption) or thermodilution (Swan-Ganz catheter).
- EuroSCORE IIEuropean System for Cardiac Operative Risk Evaluation II. Estimates operative mortality risk for adult cardiac surgery. Updated model from EuroSCORE I with improved calibration.
- CAHP Score (Cardiac Arrest Hospital Prognosis)Predicts 30-day mortality after out-of-hospital cardiac arrest (OHCA) to guide ICU admission and goals-of-care decisions.
- EGSYS Score for SyncopeEvaluation of Guidelines in SYncope Study score. Identifies cardiac vs non-cardiac cause of syncope to guide investigation and risk stratification.
- 2023 Duke-ISCVID Criteria for Infective EndocarditisUpdated 2023 Duke-ISCVID criteria for diagnosis of infective endocarditis (IE), replacing the original 2000 Duke criteria. Incorporates PET/CT and new pathogen definitions.
- ADHERE Algorithm for Acute Decompensated Heart FailureAcute Decompensated Heart Failure National Registry (ADHERE) classification and regression tree. Predicts in-hospital mortality in patients admitted with ADHF using BUN, creatinine, and systolic BP.
- Thakar Score for AKI after Cardiac SurgeryPredicts risk of acute kidney injury (AKI) requiring dialysis after cardiac surgery. Helps identify high-risk patients for preventive strategies.
- CHADS-65 Score for Atrial FibrillationCanadian Cardiovascular Society simplified stroke risk score for atrial fibrillation. Recommends anticoagulation based on age ≥65 or any CHADS risk factor.
- DAPT Score for Dual Antiplatelet Therapy DurationBalances ischaemic benefit vs bleeding risk of prolonged dual antiplatelet therapy (DAPT) after drug-eluting stent (DES) placement. Guides decision to continue or stop DAPT after 12 months.
- CART Score for Cardiac Arrest Risk TriageCardiac Arrest Risk Triage (CART) score. Predicts in-hospital cardiac arrest within 48 hours in ward patients. Enables early escalation to prevent avoidable arrests.
- Canadian TIA ScorePredicts 7-day risk of stroke after TIA or minor stroke. Guides urgency of investigation and disposition from the emergency department.
- Framingham Criteria for Heart FailureFramingham Heart Study clinical criteria for the diagnosis of heart failure. Requires 2 major OR 1 major + 2 minor criteria for diagnosis. Remains widely used in clinical practice and research.
- EUROMACS-RHF Score for Right Heart Failure after LVADPredicts right heart failure (RHF) after left ventricular assist device (LVAD) implantation. Identifies patients at high risk who may benefit from RVAD or early optimisation.
- TIMI Risk Score for UA/NSTEMIThrombolysis in Myocardial Infarction (TIMI) risk score for Unstable Angina and Non-ST-elevation MI. Predicts 14-day risk of death, MI, or urgent revascularisation.
- GRACE ACS Risk ScoreGlobal Registry of Acute Coronary Events (GRACE) score. Predicts in-hospital and 6-month mortality in patients with ACS (STEMI, NSTEMI, UA). The recommended risk stratification tool in ESC NSTEMI guidelines.
- SYNTAX Score for Coronary Artery DiseaseAnatomical scoring system grading complexity of coronary artery disease on angiography. Guides decision between PCI and CABG in multivessel or left main disease.
- ACC/AHA Pooled Cohort Equations (ASCVD Risk)2013 ACC/AHA Pooled Cohort Equations. Estimates 10-year risk of first atherosclerotic cardiovascular disease (ASCVD) event. Guides statin therapy initiation per ACC/AHA guidelines.
- CHARGE-AF Score for Incident Atrial FibrillationCohort for Heart and Aging Research in Genomic Epidemiology (CHARGE) AF score. Predicts 5-year risk of developing new-onset atrial fibrillation in patients in sinus rhythm.
- LVEF by Simpson Biplane MethodSimpson's biplane method of discs for measuring left ventricular ejection fraction (LVEF) on echocardiography. Gold standard 2D echo technique using apical 4-chamber and 2-chamber views.
- SMART2 Risk Score for Recurrent Vascular EventsSecond Manifestations of ARTerial disease (SMART) risk score. Predicts 10-year risk of recurrent cardiovascular events in patients with established atherosclerotic vascular disease.
- PREVENT Cardiovascular Risk Calculator (AHA 2023)AHA 2023 PREVENT equations. Updated 10- and 30-year CVD risk prediction including heart failure. Incorporates eGFR, replaces race-specific coefficients, applicable ages 30–79.
- MAGGIC Heart Failure Risk ScoreMeta-Analysis Global Group in Chronic Heart Failure (MAGGIC) risk calculator. Predicts 1- and 3-year all-cause mortality in patients with heart failure (both HFrEF and HFpEF).
- RV Systolic Pressure Estimation (RVSP)Estimates right ventricular systolic pressure (RVSP) / pulmonary artery systolic pressure (PASP) from Doppler echocardiography using tricuspid regurgitation jet velocity. Normal PASP <35 mmHg.
- LV Diastolic Dysfunction Assessment (ASE/EACVI 2016)2016 ASE/EACVI algorithm for patients with normal LVEF: four variables (mitral annular e', average E/e', left atrial volume index, peak TR velocity) classify diastolic function as normal, indeterminate or dysfunctional. Grading and filling-pressure estimation need mitral E velocity and E/A ratio.
- TAPSE for RV Systolic FunctionTricuspid Annular Plane Systolic Excursion (TAPSE). Simple M-mode echocardiographic measure of RV longitudinal systolic function. Normal TAPSE ≥17 mm. Reduced TAPSE correlates with worse outcomes in PAH and right heart failure.
- Wellens Syndrome ECG PatternWellens' syndrome: ECG pattern in unstable angina indicating critical proximal LAD stenosis. Two patterns: Type A (biphasic T waves V2-V3) and Type B (deep symmetric T-wave inversions V2-V3). High risk of anterior MI without intervention.
- IABP Timing AssessmentIntra-aortic balloon pump (IABP) timing assessment guide. Correct timing ensures optimal augmentation of diastolic pressure and afterload reduction. Identifies early/late inflation and deflation errors.
- Lead aVR Sign for Left Main / Proximal LAD OcclusionST elevation in lead aVR (especially ≥1 mm) with diffuse ST depression in ≥6 leads is a high-risk ECG pattern suggesting left main coronary artery or proximal LAD occlusion. Associated with high mortality.
- de Winter ECG Pattern for Proximal LAD Occlusionde Winter's ECG pattern: STEMI-equivalent caused by proximal LAD occlusion but without ST elevation. Characterised by upsloping ST depression + tall peaked T waves in precordial leads. Requires immediate reperfusion.
- HEART Score (Chest Pain Risk)Rapid risk stratification for chest pain patients in ED. Predicts 6-week MACE (death, MI, revascularisation). Guides safe discharge vs admission.
- Killip Classification (AMI Heart Failure)Classifies clinical severity of heart failure complicating acute MI. Predicts in-hospital mortality and guides ICU admission decisions.
- Pre-test Probability for Stable CAD (ESC 2019)Estimates pre-test probability (PTP) of obstructive coronary artery disease in stable chest pain (ESC 2019 guidelines). Guides non-invasive testing.
- Aortic Stenosis Severity Classification (ACC/AHA)Classifies aortic stenosis from echocardiographic parameters per the 2020 ACC/AHA valvular heart disease guideline (stages B, C1, D1; low-gradient AS flagged). Guides timing of intervention (TAVI or SAVR).
- DAPT Decision Tool (Ticagrelor vs Clopidogrel)Choice of P2Y12 inhibitor with aspirin after acute coronary syndrome, per the ESC 2023 ACS guideline.
- GRACE Score (ACS Risk)Global Registry of Acute Coronary Events (GRACE) score for in-hospital mortality in acute coronary syndrome (Granger 2003). Guides invasive vs conservative strategy.
- WHO Functional Class and Four-Strata Risk in PAH (ESC/ERS 2022)Follow-up risk assessment in pulmonary arterial hypertension with the ESC/ERS 2022 four-strata tool (COMPERA 2.0): WHO functional class, 6-minute walk distance and BNP or NT-proBNP, each graded 1–4.
- Acute Pericarditis Diagnosis (ESC 2015 Criteria)Diagnoses acute pericarditis (≥ 2 of 4 ESC criteria) and flags high-risk features that warrant hospital admission. Guides aspirin/NSAID + colchicine therapy.
- Clinically Suspected Myocarditis (ESC 2013 Criteria)Identifies suspected myocarditis using ESC 2013 diagnostic criteria. Guides CMR, endomyocardial biopsy, and activity restriction.
- SVT Termination Score and Adenosine DosingAssessment of regular narrow-complex tachycardia (SVT): vagal manoeuvres, adenosine and cardioversion per the Resuscitation Council UK tachycardia algorithm.
- Cardiac Tamponade Assessment (Beck Triad)Identifies cardiac tamponade using clinical signs and echocardiographic features. Guides urgent pericardiocentesis.
- Brugada Syndrome Diagnostic Criteria (Shanghai Score)Identifies Brugada syndrome pattern on ECG — a cause of sudden cardiac death in structurally normal hearts. Guides electrophysiology referral and ICD consideration.
- Long QT Syndrome (Schwartz Score)Estimates probability of congenital Long QT Syndrome using Schwartz-Moss criteria. Guides genetic testing, beta-blocker therapy, and ICD consideration.
- Fontan Circulation Risk AssessmentInformation page: surveillance of late complications of the Fontan circulation.
- PCSK9 Inhibitor Eligibility (NICE TA393 / TA394)Checks the NICE TA393 (alirocumab) / TA394 (evolocumab) LDL-C thresholds for adults with primary hypercholesterolaemia or mixed dyslipidaemia on maximal tolerated lipid-lowering therapy.
- QRISK3 — 10-Year Cardiovascular RiskQRISK3 (Hippisley-Cox 2017) estimates the 10-year risk of heart attack or stroke in adults aged 25–84 without cardiovascular disease. NICE NG238 uses it for primary-prevention statin decisions.